VitaNova Life Sciences (VNOV) EBITDA (2017 - 2026)

VitaNova Life Sciences (VNOV) reported EBITDA of $46731.0 for Q1 2026, down 57.08% on a YoY basis from $108874.0 in Q1 2025, and down 52.88% quarter-over-quarter from $99170.0 in Q4 2025.

VitaNova Life Sciences (VNOV) EBITDA (2017 - 2026) Analysis & Trends

VitaNova Life Sciences has reported EBITDA for 10 years, with the latest figure at $46731.0 in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA fell 57.08% year-over-year to $46731.0; the trailing twelve-month figure through Jan 2026 stood at $1.2 million (up 233.31% YoY), and the FY2025 full-year result was $1.2 million, up 487.62% from the prior year.
  • EBITDA for Q1 2026 stood at $46731.0, down from $99170.0 in the prior quarter.
  • The five-year high for EBITDA was $1.1 million in Q2 2025, with the low at -$45414.0 in Q3 2024.
  • Historically, EBITDA has averaged $90016.9 across 5 years, with a median of $2601.0 in 2022.
  • Annual changes were most pronounced in 2023 — EBITDA slumped 1236.22% — and 2024, when it surged 5406.34%.
  • VitaNova Life Sciences' EBITDA stood at $2601.0 in 2022, then plunged by 436.6% to -$8755.0 in 2023, then soared by 815.02% to $62600.0 in 2024, then jumped by 58.42% to $99170.0 in 2025, then plunged by 52.88% to $46731.0 in 2026.
  • The last three EBITDA figures came in at $46731.0 (Q1 2026), $99170.0 (Q4 2025), and -$32440.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn 2.15 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 1.27 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn 509.00 Mn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn 182.00 Mn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn 46.01 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn -7.37 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn -2.38 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn -3.10 Mn
10 VitaNova Life Sciences - - 316,343.00 46,731.00

Historic Data

Download Data
DateValue
Jan 31, 2026 46,731.00
Oct 31, 2025 99,170.00
Jul 31, 2025 -32,440.00
Apr 30, 2025 1.08 Mn
Jan 31, 2025 108,874.00
Oct 31, 2024 62,600.00
Jul 31, 2024 -45,414.00
Apr 30, 2024 232,683.00
Jan 31, 2024 5,948.00
Oct 31, 2023 -8,755.00
Jul 31, 2023 -24,247.00
Apr 30, 2023 -4,385.00
Jan 31, 2023 -24,577.00
Oct 31, 2022 2,601.00
Jul 31, 2022 2,134.00
Apr 30, 2022 1,937.00
Jan 31, 2022 25,173.00
Oct 31, 2021 -29,991.00
Jul 31, 2021 -10,486.00
Apr 30, 2021 -7,196.00